Chemically reactive intermediates and pulmonary xenobiotic therapy

Pharmacological Reviews

Volumn 49, Issue 4, 1997, Pages 297-341

  Gram, Theodore E ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLNAPHTHALENE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 IPOMEANOL; BENZO[A]PYRENE; BLEOMYCIN; BUTYLCRESOL; CYTOCHROME P450; FURAN DERIVATIVE; GLUTATHIONE; NAPHTHALENE; NITROFURANTOIN; PARAQUAT; REACTIVE OXYGEN METABOLITE; SKATOLE; UNSPECIFIC MONOOXYGENASE; VINYLIDENE CHLORIDE; XENOBIOTIC AGENT;

COVALENT BOND; DNA ADDUCT; DRUG DNA INTERACTION; GLUTATHIONE METABOLISM; HUMAN; HYPEROXIA; LUNG CARCINOGENESIS; LUNG INJURY; LUNG TOXICITY; LUNG TUMOR; MUTAGENICITY; NONHUMAN; OXYGEN TOXICITY; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; STEREOCHEMISTRY; TOBACCO; XENOBIOTIC METABOLISM;

ANIMALS; ANTI-INFECTIVE AGENTS, URINARY; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BENZO(A)PYRENE; BIOTRANSFORMATION; BLEOMYCIN; BUTYLATED HYDROXYTOLUENE; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; DICHLOROETHYLENES; DNA ADDUCTS; HERBICIDES; HYPEROXIA; LUNG; LUNG NEOPLASMS; NAPHTHALENES; NITROFURANTOIN; NITROSAMINES; PARAQUAT; SKATOLE; TERPENES; XENOBIOTICS;

EID: 0031461130     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (282)

1. ADAMS, J. D., HEINS, M. C., AND YOST, G. S.: 3-Methylindole inhibits lipid peroxidation. Biochem. Biophys. Res. Commun. 149: 73-78, 1987.
2. ADAMSON, I. Y. R., AND BOWDEN, D. H.: The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77: 185-198, 1974.
3. ADAMSON, I. Y. R., BOWDEN. D. H., COTE, M. G., AND WITSCHI, H. P.: Lung injury induced by butylated hydroxyloluene: cytodynamic and biochemical studies in mice. Lab. Invest. 36: 26-32, 1977.
4. ADAMSON, I. Y. R., BOWDEN, D. H., AND WYATT, J. P.: Oxygen poisoning in mice: ultrastructural and surfactant studies during exposure and recovery. Arch. Pathol. 90: 463-472, 1970.
5. AGARWAL, S., AND SOHAL, R. S.: DNA damage and life expectancy in houseflies Proc. Natl. Acad. Sci. USA 91: 12332-12335, 1994.
6. AUTOR, A. P.: Reduction of paraquat toxicity by superoxide dismutase. Life Sci. 14: 1309-1319, 1974.
7. BARRY, B. E., AND CRAPO, J. D.: Application of morphometric methods to study diffuse and focal injury in the lung caused by toxic agents. CRC Crit. Rev. Toxicol. 14: 1-32, 1985.
8. BECKER, G. M., BREEZE, R. G., AND CARLSON, J. R.: Autoradiographic evidence of 3-methylindole covalent binding to pulmonary epithelial cells in the goat Toxicology 31: 109-121, 1984.
9. BECKER, G. M., NOCERINI, M. R., CARLSON, J. R., AND BREEZE, R. G.: Alkylation of bronchiolar epithelial cells by 3-methylindole in the horse. Toxicol. Lett. 24: 25-32, 1985.
10. 6-methylguanine in rat pulmonary cells. Carcinogenesis 9: 2053-2058, 1988.
11. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 50: 3772-3780, 1990.
12. BELINSKY, S. A., WHITE, C. M., BOUCHERON, J. A., RICHARDSON, F. C., SWENBERG, J. A., AND ANDERSON, M.: Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 46: 1280-1284, 1986.
13. BKLINSKY, S. A., WHITE, C. M., DEVEREUX, T. R., SWENBERG, J. A., AND ANDERSON, M. W.: Cell selective alkylation of DNA in rat lung following low-dose exposure to the tobacco-specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 47: 1143-1148, 1987.
14. BEND, J. R., SERABJIT-SINGH, C. J., AND PHILPOTT, R. M.: The pulmonary uptake, accumulation and metabolism of xenobiotics. Annu. Rev. Pharmacol. Toxicol. 25: 97-145, 1985.
15. BENEDETTI, A., AND COMPORTI, M.: Formation, reactions and toxicity of aldehydes in the course of lipid peroxidation in cellular membranes. Bioelectrochem. Bioenerg. 18: 187-202, 1987.
16. BENEDETTI, A., COMPORTI, M., AND ESTERBAUER, H.: Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta. 620: 281-296, 1980.
17. BISHOP, C. T., FREEMAN, B. A., AND CRAPO, J. D.: Free radicals and lung injury. In Free Radicals in Molecular Biology, Aging and Disease, ed. by Armstrong, D. R., pp. 381-389, Raven Press, New York, 1984.
18. BLOCK, E. R.: Potentiation of acute paraquat toxicity by vitamin E deficiency. Lung 156: 195-203, 1979.
19. BOLT, H. M., LAIB, R. J., AND FILSER, J. G.: Commentary: reactive metabolites and carcinogenicity of halogenated ethylenes. Biochem. Pharmacol. 31: 1-4, 1982.
20. BOLTON, J. L., SEVESTRE, H., IBE, B. O., AND THOMPSON, J. L.: Formation and reactivity of alternative quinone methides from butylated hydroxytoluene possible explanation for species-specific pneumotoxicity. Chem. Res. Toxicol. 3: 65-70, 1990.
21. BOLTON, J. L., AND THOMSON, J. A.: Oxidation of butylated hydroxyloluene to toxic metabolites: factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary microsomes. Drug Metab. Dispos. 19: 467-472, 1991.
22. BOLTON, J. L., THOMPSON, J. A., ALLENTOFF, A. J., MILEY, F. B., AND MALKINSON, A. M.: Metabolic activation of butylated hydroxytoluene by mouse bronchiolar Clara cells. Toxicol. Appl. Pharmacol. 123: 43-49, 1993
23. BOWDEN, D. H., ADAMSON, I. Y. R., AND WYATT, J. P.: Reaction of the lung cells to a high concentration of oxygen. Arch. Pathol. 86: 671-675, 1968.
24. BOYD, M. R.: Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. Crit. Rev. Toxicol. 7: 103-176, 1980c.
25. BOYD, M. R.: Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase in lung. Nature (Lond.) 269: 713, 1977.
26. BOYD, M. R.: Metabolic activation and lung toxicity: a basis for cell-selective. pulmonary damage by foreign chemicals. Environ. Health Perspect. 55 47-51, 1984.
27. BOYD, M. R.: Role of metabolic activation in the pathogenesis of chemically induced pulmonary disease: mechanism of action of the lung-toxic furan, 4-ipomeanol. Environ. Health Perspect. 16: 127-138, 1976.
28. BOYD, M. R., BUCKPITT, A. R., JONES, R. B., STATHAM, C. N., DUTCHER, J. S., AND LONGO, N. S.: Metabolic activation of toxins in extrahepatic organs and target cells. In The Scientific Basis of Toxicity Assessment, ed. by H. P. Witschi, pp. 141 152, Elsevier/North Holland Biomedical Press. Amsterdam, 1980a.
29. BOYD, M. R., AND BURKA, L. T.: In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. J. Pharmacol. Exp. Ther. 207: 687-697, 1978.
30. 14C] 4-ipomeanol. Toxicol. Appl. Pharmacol. 32: 147-157.
31. BOYD, M. R., BURKA, L. T., WILSON, B. J., AND RAMA, B. V.: Development of tolerance to the pulmonary toxin, 4-ipomeanol. Toxicology 19: 85-100, 1981.
32. BOYD, M. R., CATIGNANI, G. L., SASAME, H. A., MITCHELL, J. R., AND STID A. W.: Acute pulmonary injury in rats by nitrofurantoin and modification by vitamin E. dietary fat, and oxygen. Am. Rev. Respir. Dis. 120: 93-99, 1979.
33. JOYD, M. R., AND DUTCHER, J. S.: Renal toxicity to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse. J. Pharmacol. Exp. Ther. 216: 640-646, 1981.
34. JOYD, M. R., STATHAM, C. N., FRANKLIN, R. B., AND MITCHELL, J. R.: Pulmonary bronchiolar alkylation and necrosis by 3-methylfuran, a naturally occurring potential atmospheric contaminant. Nature (Lund.) 272: 270-271, 1978.
35. BOYD, M. R., STATHAM, C. N., AND LONGO, N. S.: The pulmonary Clara cell as a target for toxic chemicals requiring metabolic activation: studies with carbon tetrachloride. J. PharmacOl. Exp. Ther. 212: 109-114, 1980b.
36. BOYD, M. R., STIKO, A., STATHAM, C. N., AND JONES, R. B.: Protective role of endogenous pulmonary glutathione und other sulfhydryl compounds against lung damage by alkylating agents: investigations with 4-ipumeanol in the rat. Biochem. Pharmacol. 31: 1579-1583, 1982.
37. BRADLEY, B. J., AND CARLSON, J. R.: Ultrastructural pulmonary changes induced by intravenously administered 3-methylindole in goats. Am. J. Pathol. 99: 551-560, 1980.
38. BRAY, T. M., AND CARLSON, J. R.: Role of mixed-function oxidase in 3-methylindole-induced acute pulmonary edema in goats. Am. J. Vet. Res. 40: 1268-1272, 1979.
39. 14C] methylindole metabolites in goat tissues. Proc. Soc. Expt. Biol. Med. 176: 48-53, 1984.
40. BRAY, T. M., AND EMMERSON, K. S.: Putative mechanisms of toxicity of 3-methylindole: from free radical to pneumotoxicosis. Ann. Rev. Pharmacol. Toxi-col. 34: 91-115, 1994.
41. BRAY, T. M., AND KIRKLAND, J. B.: The metabolic basis of 3-methylindole-induced pneumotoxicity. Pharmacol. Ther. 46: 105-118, 1990.
42. BRODIE, B. B.: Idiosyncracy and intolerance. In Ciba Foundation Symposium on Drug Responses in Man, ed. by G. E. W. Wolstenholme and R. Porter, pp. 188-218, J. and A. Churchill, London, 1967.
43. BRODIE, B. B., AND MAICKEL, R.: Metabolic Factors Controlling the Duration of Drug Action, eds. B. B. Brodie and E. G. Erdos, pp. 299-324, Pergramon Press, Oxford, 1962.
44. BROOKS, P., AND LAWLEY, P. W.: Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acid. Nature (Lond.) 202: 781-784, 1964.
45. BUCKFITT, A., BUONARATI, M., BAHNSON AVEY, L., CHANG, A. M., MORIN, D., AND PLOPPER, C. G.: Relationship of cytochrome P450 activity to Clara cell cytotoxicity II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat, and rhesus monkey. J. Pharmacol. Exp. Ther. 261: 364-372, 1992.
46. BUCKPITT, A., CHANG, A. M., WEIR, A., VAN WINKLE, L., DUAN, X., PHILPOT, R., AND PLOPPER, C.: Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats and hamsters. Mol. Pharmacol. 47: 74-81, 1005.
47. BUCKPITT, A. R., AND BAHNSON L. S.: Naphthalene metabolism by human lung microsomal enzymes. Toxicology 41: 333-341, 1986.
48. BUCKPITT, A. R., BAHNSON, L. S., AND FRANKLIN, R. B.: Evidence that 1-naphthol is not un obligate intermediate in the covalent binding and the pulmonary bronchiolar necrosis by naphthalene. Biochem. Biophys. Res. Commun. 126: 1097-1103, 1985.
49. BUCKPITT, A. R., BAHNSON, L. S., AND FRANKLIN, R. B.: Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation. J. Pharmacol. Exp. Ther. 231: 291-300, 1984.
50. BUCKPITT, A. R., AND BOYD, M. R.: In vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar alkylating agent and cytotoxin, 4-ipomeanol. J. Pharmacol. Exp. Ther. 215: 97-103, 1980.
51. BUCKFITT, A. R., AND BOYD, M. R.: Metabolic activation of 4-ipomeanol by avian tissue microsomes. Toxicol. Appl. Pharmacol. 68: 53-62, 1982a.
52. BUCKPITT, A. R., CASTAGNOLI, N., NELSON, S. D., JONES, A. D., AND BAHNSON, L. S.: Stereoselectivity of naphthelene epoxidation by mouse, rat and hamster pulmonary, hepatic, and renal enzymes. Drug Metab. Dispos. 15: 491-498, 1987.
53. BUCKPITT, A. R., AND FRANKLIN, R. B.: Relationship of naphthalene and 2-methylnuphthalene metabolism to pulmonary bronchiolar epithelial cell necrosis. Pharmacol. Ther. 41: 393-410, 1989.
54. BUCKPITT, A. R., STATHAM, C. N., AND BOYD, M. R.: In vivo studies on the target tissue metabolism, covalent binding, glutathione depletion and toxicity in birds, species deficient in pulmonary enzymes for metabolic activation. Toxicol. Appl. Pharmacol. 65: 38-52, 1982b.
55. BUCKPITT, A. R., AND WARREN, D. L.: Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo. J. Pharmacol. Exp. Ther. 225: 8-16, 1983.
56. BUENING, M. K., WISLOCKI, P. G., LEVIN, W., YAGI, H., THAKKER, D. R., AKAGI, H., KOREEDA, M., JERINA, D. M., AND CONNEY, A. H.: Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7β, 8α-dihydroxy-9α, 10α-epoxy-7,8,9,10 tetrahydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. USA 75: 5358-5361, 1978.
57. BUONARATI, M., JONES, A. D., AND BUCKPITT, A.: In vivo metabolism of isomeric naphthalene oxide glutathione conjugates. Drug Metab. Dispos. 18: 183-189, 1990.
58. BUONARATI, M., MORIN, D., PLOPPER, C., AND BUCKPITT, A. R.: Glutathione depletion und cytotoxicity by naphthalene 1,2-oxide in isolated hepatocytes. Chem. Biol. Interact. 71: 147-165, 1989.
59. BURGER, R. M., BERKOWITZ, A. R., PEISACH, J., AND HORWITZ, S. B.: Origin of malondialdehyde from DNA degraded by Fe(II), bleomycin. J. Biol. Chem. 255: 11812-11838, 1980.
60. BURK, R. F., LAWRENCE, R. A., AND LANE, J. M.: Liver necrosis and lipid peroxidation in the rat as the result of paraquat and diquat administration: effect of selenium deficiency. J. Clin. Invest. 65: 1024-1031, 1980.
61. BUS, J. S., AUST, S. D., AND GIBSON, J. E.: Puraquat toxicity: proposed mechanism of action involving lipid peroxidation. Environ. Health Perspect. 16: 139-146, 1976a.
62. BUS, J. S., CAGEN, S. Z., OLGAARD, M., AND GIBSON, J. E.: A mechanism of paraquat toxicity in mice and rats. Toxicol. Appl. Pharmacol. 35: 501-513, 1976b.
63. BUS, J. S., AND GIBSON, J. E.: Paraquat: model for oxidant-initiated toxicity. Environ. Health Perspect. 55: 37-46, 1984.
64. CASINI, A., GIORLI, M., HYLAND, R. J., SERRONI, A., FILFOR, D., AND FARBER, J. I.: Mechanisms of cell injury in the killing of cultured hepatocytes by bromobenzene. J. Biol. Chem. 257: 6721-6728, 1982.
65. CHANG, A., BUCKPITT, A., PLOPPER, C., AND ALWORTH, W.: Suicide inhibition of CYP2F2, the enzyme responsible for naphthalene metabolism to a Clara cell toxicant. Toxicologist 30: 376, 1996.
66. CHEN, L. J., HECHT, S. S., AND PETERSON, L. A.: Identification of cis-2-butene-1,4 dial as a mitrosomal metabolite of furan. Chem. Res. Toxicol. 8: 903-908, 1995.
67. CHICHESTER, C. H., BUCKPITT, A. R., CHANG, A., AND PLOPPER, C. G.: Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells. Mol. Pharmacol. 45: 664-672, 1994.
68. CHO, M., CHICHESTER, C., PLOPPER, C. G., AND BUCKPITT, A.: Biochemical factors important in Clara cell selective toxicity in the lung. Drug Metab. Rev. 27: 369-386, 1995,
69. COMBS, G. F., AND PETERSON, F. J.: Protection against acute paraquattoxicity by dietary selenium in the chick. J. Nutr. 113: 538-545, 1983.
70. COMPORTI, M.: Glutathione depleting agents and lipid peroxidation. Chem. Phys. Lipids 45: 143-169, 1987.
71. CONNEY, A. H.: Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes memorial lecture. Cancer Res. 42: 4875-4917, 1982.
72. CONNEY, A. H., CHANG, R. L., JERINA, D. M., AND WEI, S. J. C.: Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 26: 125-163, 1994.
73. COSTA, A. K., AND IVANETICH, K. M.: Chlorinated ethylenes: their metabolism and effect on DNA repair in rat hepatocytes. Carcinogenesis 5: 1629-1636, 1984.
74. COSTA, A. K., AND IVANETICH, K. M.: Vinylidene chloride: its metabolism by hepatic microsomal cytochrome P450 in vitro. Biochem. Pharmacol. 31: 2083-2092, 1982.
75. COSTA, E., KARCZMAR, A. G., AND VESELL, E. S.: Bernard B. Brodie and the rise of chemical pharmacology. Annu. Rev. Pharmacol. Toxicol. 29: 1-21, 1989.
76. CRAPO, J. D., BARRY, B. E., FOSCUE, H. A., AND SHELBURNE, J.: Structural and biochemical changes in rat lungs occurring during exposure to lethal and adaptive doses of oxygen. Am. Rev. Respir. Dis. 122: 123-143, 1980.
77. CRAPO, J. D., GOLDEN, M., SALIN, J., AND SHELBURNE, J. S.: Pathologic changes in the lungs of oxygen-adapted rats: a morphometric analysis. Lab. Invest. 39: 640-653, 1978.
78. CRESPI, C. L., PENMAN, B. W., GELBOIN, H. V., AND GONZALEZ, F. J.: A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P450 206. Carcinogenesis 12: 1197-1201, 1991.
79. CZERWINSKI, M., MCLEMORE, T. L., PHILPOT, R. L., NHAMBURO, P. T., KORZEKWA, K., GELBOIN, H. V., AND GONZALEZ, F. J.: Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P450: evidence for species-specific metabolism. Cancer Res. 51: 4636-4638, 1991.
80. DELEVE, L. D., AND KAPLOWITZ, N.: Glutathione metabolism and its role in hepatotoxicity. Pharmacol. Ther. 52: 287-305, 1991.
81. DENISSENKO, M. F., PAO, A., TANG, M. S., AND PFEIFER, G. P.: Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in P53. Science (Wash. DC) 274: 430-432, 1996.
82. DEVALIA, J. L., OGILVIA, R. C., AND MCLEAN, A. E. M.: Dissociation of cell death from covalent binding of paracetamol by flavones in a hepatocyte system. Biochem. Pharmacol. 31: 3745-3750, 1982.
83. DEVEREUX, T. R., JONES, K. G., BEND, J. R., FOLTS, J. R., STATHAM, C. N., AND BOYD, M. R.: In vitro metabolic activation of the pulmonary toxin, 4-ipomeanol, in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lung. J. Pharmacol. Exp. Ther. 220: 223-227, 1981.
84. DEVEREUZ, T. R., ANDERSON, M. W., AND BELINSKY, S. A.: Factors regulating activation and DNA alkylation by 4-(N-methyl-N-nitrosamino-1-(3-pyridyl)-1-butanone and nitrosodimethylamine in rat lung and isolated lung cells and the relationship to carcinogenicity. Cancer Res. 48: 4215-4221, 1988.
85. DINSLALE, D., VERSCHOYLE, R. D., AND COBRAL, J. R.: Cellular responses to trialkylphosphorothioate-induced injury in rat lung. Arch. Toxicol. 51: 79-89, 1982.
86. DINSDALE, D., VERSCHOYLE, R. D., AND INGHAM, J. E.: Ultrantructural changes in rat Clara cells induced by a single dose of O,S,S-trimethylphosphorodithioate. Arch. Toxicol. 66: 59-65, 1984.
87. DOELMAN, C. J. A., AND BAST, A.: Oxygen radicals in lung pathology. Free Radical Biol. Med. 9: 381-400, 1990.
88. DORR, R. T.: Bleomycin pharmacology: mechanisms of action and resistance and clinical pharmacokinetics. Semin. Oncol. 19(suppl. 5): S3-S8, 1992.
89. DOWSLEY, T. F., FORKERT, P. G., BENESCH, L. A., AND BOLTON, J. L.: Reaction of glutathione with electrophilic metabolites of 1,1-dichloroethylene. Chem. Biol. Interact. 95: 227-244, 1995.
90. DOWSLEY, T. F., ULLREICH, J. B., BOLTON, J. L., PARK, S. S., AND FORKERT, P. G.: CYP2E1-dependent bioactivation of 1,1-dichloroethylene in murine lung: formation of reactive intermediates and glutathione conjugates. Toxicol. Appl. Pharmacol. 139: 42-48, 1996.
91. DUAN, X., PLOPPER, C., BRENNAN, P., AND BUCKPITT, A.: Rates of glutathione synthesis in lung subcompartments of mice and monkeys: possible role in species and site selective injury. J. Pharmacol. Exp. Ther. 277: 1-8, 1996.
92. DURHAM, S. K., AND CASTLEMAN, W. L.: Pulmonary lesions induced by 3-methylindole in mice. Am. J. Pathol. 121: 128-137, 1985.
93. DUTCHER, J. S., AND BOYD, M. R.: Species and strain differences in target organ alkylation and toxicity by 4-ipomeanol: predictive value of covalent binding in studies of target organ toxicities by reactive metabolites. Biochem. Pharmacol. 28: 3367-3372, 1979.
94. FELDMAN, G., REMSEN, J., WANG, T. V., AND CERUTTI, P.: Formation and excision of covalent deoxyribonucleic acid adducts of benzo[a]pyrene 4,5-epoxide and benzo[a]pyrene epoxide I in human lung cells A549. Biochemistry 19: 1095-1101, 1980.
95. FILDERMAN, A. E., AND LAZO, J. S.: Murine strain differences in pulmonary bleomycin metabolism. Biochem. Tharmacol. 42: 195-198, 1991.
96. FISHER, H. K., CLEMENTS, J. A., AND WRIGHT, R. R.: Enhancement of oxygen toxicity by the herbicide paraquat. Am. Rev. Respir. Dis. 107: 246-252, 1973.
97. FORKERT, P. G.: CYP2E1 is preferentially expressed in Clara cells of murine lung: localization by in situ hybridization and immunohistochemical methods. Am. J. Respir. Cell Mol. Biol. 12: 589-596, 1995.
98. FORKERT, P. G., AND BIRCH, D. W.: Pulmonary toxicity of trichloroethylene in mice: covalent binding, and morphological manifestations. Drug Metab. Dispos. 17: 106-113, 1989.
99. FORKERT, P. G., COLLINS, K. S., DOWSLEY, T. F., AND Ross, G. M.: Immunochemical assay for recognition of 2-S-glutathionyl: acetate, a glutathione conjugate derived from 1,1-dichloroethylone-epoxide. J. Pharmacol. Exp. Ther. 280: 1422-1430, 1997.
100. FORKERT, P. G., FORKERT, L., FAROOQUI, M., AND REYNOLDS, E. S.: Lung injury and repair: DNA synthesis following 1,1-dichloroethylene. Toxicology 36: 119-214, 1985.
101. FORKERT, P. G., GEDDES, B. A., BIRCH, D. W., AND MASSEY, T. E.: Morphologic changes and covalent binding of 1,1-dichloroethylene in Clara and alveolar type II cells isolated from lungs of mice following in vivo administration. Drug Metab. Dispos. 18: 534-539, 1990.
102. FORKERT, P. G., HOFLEY, M., AND RACZ, W. J.: Metabolic activation of 1,1-dichloroethylene by mouse lung and liver microsomes. Can. J. Physiol. Pharmacol. 65: 1496-1499, 1987.
103. FORKERT, P. G., LEE, R. P., DOWSLEY, T. F., HONG, J. Y., AND ULREICH, J. B.: Protection from 1,1-dichloroethylene-induced Clara cell injury by diallyl sulfone, a derivative of garlic. J. Pharmacol. Exp. Ther. 277: 1665-1671, 1996.
104. FORKERT, P. G., MASSEY, T. E., JONES, A. B., PARK, S. S., GELBOIN, H. V., AND ANDERSON, L. M.: Distribution of CYP2E1 in murine liver after ethanol and acetone administration. Carcinogenesis 12: 2259-2268, 1991.
105. FORKERT, P. G., AND MOUSSA, M.: Temporal effects of 1,1-dichloroethylene on nonprotein sulfhydryl content in murine lung and liver. Drug Metab. Dispos. 21: 770-776, 1993.
106. FORKERT, P. G., REDZA, Z. M., MANGOS, S., PARK, S. S., AND TAM, S. P.: Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration. Drug Metab. Dispos. 22: 248-253, 1994.
107. FORKERT, P. G., AND REYNOLDS, E. S.: 1,1-Dichloroethylene induced pulmonary injury. Exp. Lung Res. 3: 57-68, 1982.
108. FORKERT, P. G., STRINGER, V., AND RACZ, W. J.: Effects of administration of metabolic inducers and inhibitors on pulmonary toxicity and covalent binding by 1,1-dichloroethylene in CD-1 mice. Exp. Mol. Pathol. 45: 44-58, 1986.
109. FORKERT, P. G, AND TROUGHTON, K. M.: Airway injury by trichloroethylene: a scanning electron microscopic study. J. Pathol. 152: 119-125, 1987.
110. FOTH, H.: Role of the lung in accumulation and metabolism of xenobiotic compounds - implications for chemically induced toxicity. CRC Crit. Rev. Toxicol. 25: 165-205, 1995.
111. FRANK, L., AND MASSARO, D.: The lung and oxygen toxicity. Arch. Intern. Med. 139: 347-350, 1979.
112. FREEMAN, B. A., AND CRAPO, J. D.: Biology of disease: free radicals and tissue injury. Lab. Invest. 47: 412-426, 1982.
113. GANDY, J., ALI, F. A., HASEGAWA, L., AND IMAMURA, T.: Morphological alterations of rat lung bronchiolar epithelium produced by various trialkylphosphorothioates. Toxicology 32: 37-46, 1984.
114. GANDY, J., AND IMAMURA, T.: Cellular response to O,O,S-trimethylphosphorothioate-induced pulmonary injury in rats. Toxicol. Appl. Pharmacol. 80: 51-57, 1985.
115. GANDY, J., TALBOT, P., FUKUTO, T. R., AND IMAMURA, T.: Phenobarbital pretreatment protects against morphologic changes in rat bronchiolar epithelium caused by an impurity of malathion. Am. J. Pathol. 111: 350-353, 1983.
116. GELBOIN, H. V.: Cytochrome P450 and monoclonal antibodies. Pharmacol. Rev. 46: 413-453, 1993.
117. GELBOIN, H. V.: A microsome-dependont binding of benzo[a]pyrene to DNA. Cancer Res. 29: 1272-1276, 1969.
118. GILLETTE, J. R.: Commentary: a perspective on the role of chemically reactive metabolites of foreign compounds in toxicity: I - correlation of changes in covalent binding of reactive metabolites with changes in the incidence and severity of toxicity. Biochem. Pharmacol. 23: 2785-2794, 1974a.
119. GILLETTE, J. R.: Commentary: a perspective on the role of chemically reactive metabolites of foreign compounds in toxicity: II - alterations in the kinetics of covalent binding. Biochem. Pharmacol. 23: 2927-2938, 1974b.
120. GILONI, L., TAKESHITA, M., JOHNSON, F., IDEM, C., AND GROLLMAN, A. P.: Bleomycin-induced strand-scission of DNA: mechanism of deoxyribose cleavage. J. Biol. Chem. 256: 8608-8615, 1981.
121. GONDER, J. C., PROCTOR, R. A., AND WILL, J. A.: Genetic differences in oxygen toxicity are correlated with cytochrome P450 inducibility. Proc. Natl. Acad. Sci. USA 82: 6315-6319, 1985.
122. GOULD, V. E., TOSCO, R., WHEELIH, R. F., GOULD, N. S., AND KAPANCI, Y.: Oxygen pneumonitis in man: ultrastructural observations on the development of alveolar lesions. Lab. Invest. 26: 499-508, 1972.
123. GREENBERG, D. B., REISER, K. M., AND LAST, J. A.: Correlation of biochemical and morphologic manifestations of acute pulmonary fibrosis in rats administered paraquat. Chest 74: 421-425, 1978.
124. GRIFFIN, K. A., JOHNSON, C. B., BREGER, R. K., AND FRANKLIN, R. B.: Pulmonary toxicity, hepatic and extrahepatic metabolism of 2-methylnaphthalene in mice. Toxicol. Appl. Pharmacol. 61: 185-196, 1981.
125. GRIFFIN, K. A., JOHNSON, C. B., BREGER, R. K., AND FRANKLIN, R. B.: Effects of inducers and inhibitors of cytochrome P450-linked monooxygenases on the toxicity, in vitro metabolism and in vivo irreversible binding of 2-methylenaphthalene in mice. J. Pharmacol. Exp. Ther. 221: 517-524, 1982.
126. GROVER, P. L., AND SIMS, P.: Enzyme-catalysed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vivo. Biochem. J. 110: 159-160, 1968.
127. GUENGERICH, F. P., AND SHIMADA, T.: Oxidation of carcinogenic chemicals by human cytochrome P450 enzymes. Chem. Res. Toxicol. 4: 391-407, 1991.
128. HAGEN, T. M., BROWN, L. A., AND JONES, D. P.: Protection against paraquat-induced injury by exogenous GSH in pulmonary type II cells. Biochem. Pharmacol. 38: 4537-4542, 1986.
129. HALLIWELL, B., AND GUTTERIDGE, J. M. C.: Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch. Biochem. Biophys. 246: 501-514, 1986.
130. HALLIWELL, B., AND GUTTERIDGE, J. M. C.: Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219: 1-14, 1984.
131. HAMMOND, A. C., CARLSON, J. R., AND WILLETT, J. D.: The metabolism and disposition of 3-methylindole in goats, Life Sci. 25: 1301-1306, 1979.
132. HANAFLY, M. S. M., AND BOGAN, J. A: The covalent binding of 3-methylindole metabolites to bovine tissue. Life Sci. 27: 1225-1231, 1980.
133. HARRISON, G. A.: Ultrastructural changes in rat lung during long-term exposure to oxygen. Exp. Med. Surg. 29: 96-101, 1971.
134. HARRISON, J. H., HOYT, D. G., AND LAZO, J. S.: Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice. Mol. Pharmacol. 36: 231-238, 1989.
135. HARVEY, R. G.: Polycyclic hydrocarbons and cancer. Am. Sci. 70: 386-393, 1982.
136. HASCHEK, W. M., BOYD, M. R., HAKKINEN, P. J., OWENBY, C. S., AND WITSCHI, H. P.: Acute inhalation toxicity of 3-methylfuran in the mouse: pathology, cell kinetics, and respiratory rate effects. Toxicol. Appl. Pharmacol. 72: 124-133, 1984.
137. HASCHEK, W. M., MORSE, C. C., BOYD, M. R., HAKKINEN, P. J., AND WITSCHI, H. P.: Pathology of acute inhalation exposure to 3-methylfuran in the rat and hamster. Exp. Mol. Pathol. 39: 342-354, 1983.
138. HAY, J., SHAHZEIDI, S., AND LAURENT, G.: Mechanisms of bleomycin-induced lung damage. Arch. Toxicol. 65: 81-94, 1991.
139. HECHT, S. S.: Metabolic activation and detoxification of tobacco-specific nitrosamines: a model for cancer prevention strategies. Drug Metab. Rev. 373-390, 1994.
140. HECHT, S. S., TRUSHIN, N., CASTONGUAY, A., AND RIVENSON, A.: Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. Cancer Res. 46: 498-502, 1986.
141. 14C]naphthol formed by rat liver microsomes. Mol. Pharmacol. 16: 667-675, 1979.
142. HEWITT, W. R., AND PLAA, G. L.: Dose-dependent modification of 1,1-dichloro-ethylene toxicity by acetone. Toxicol. Lett. 16: 145-152, 1983.
143. HlNSON, J. A., AND ROBERTS, R. W.: Role of covalent and noncovalent interactions in cell toxicity: effects on proteins. Ann. Rev. Pharmacol. Toxicol. 32: 471-510, 1992.
144. Hirai, K. I., WITSCHI, H. P., AND COTE, M. G.: Electron microscopy of butylated hydroxytoluene-induced lung damage in mice. Exp. Mol. Pathol. 27: 295-308, 1977.
145. HOFFMANN, D., RIVERSON, A., AMIN, S., AND HECHT, S. S.: Dose-response study of the carcinogenicity of tobacco-specific N-nitrosamines in F344 rats. J. Cancer Res. Clin. Oncol. 108: 81-86, 1984.
146. HOYT, D. G., AND LAZO, J. S.: Alterations in pulmonary mRNA encoding protocollagens, fibronectin, and transforming growth factor-β procedes bleo-mycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 246: 765-771, 1988.
147. HOYT, D. G., AND LAZO, J. S.: Murine strain differences in acute lung injury and activation of poly (ADP-ribose) polymerase by in vitro exposure of lung slices to bleomycin. Am. J. Resp. Cell. Mol. Biol. 7: 645-651, 1992.
148. HUANG, T. W., CARLSON, J. R., BRAY, T. M., AND BRADLEY, B. J.: 3-Methylindole-induced pulmonary injury in goats. Am. J. Pathol. 87: 647-666, 1977.
149. HUIJZER, J., ADAMS, J. D., AND YOST, G. S.: Decreased pneuomotoxicity of deuterated 3-methylindole: bioactivation requires methyl C-H bond breakage. Toxicol. Appl. Pharmacol. 90: 60-68, 1987.
150. HUIJZER, J. C., ADAMS, J. D., JAW, J. Y., AND YOST, G. S.: Inhibition of 3-methylindole bioactivation by the cytochrome P450 suicide substrates 1-aminobenzotriazole and α-methylbenzo-triazole. Drug Metab. Dispos. 17: 37-42, 1989.
151. ILETT, K. F., STRIPP, B., MENARD, R. H., REID, W. D., AND GILLETTE, J. R.: Studies on the mechanism of the lung toxicity of paraquat: comparison of tissue distribution and some biochemical parameters in rats and rabbits. Toxicol. Appl. Pharmacol. 28: 216-226, 1974.
152. IMAMURA, T., GANDY, J., AND FUKUTO, T. R.: Selective inhibition of rat pulmonary monooxygenase by O,O,S-trimethyl phosphorothioate treatment. BiocheM. Pharmacol. 32: 3191-3195, 1983a.
153. IMAMURA, T., GANDY, J., FUKUTO, T. R., AND TALBOT, P.: An impurity of malathion alters the morphology of rat lung bronchiolar epithelium. Toxicology 26: 73-79, 1983b.
154. IMAMURA, T., AND HASEGAWA, L.: Role of metabolic activation, covalent binding, and glutathione depletion in pulmonary toxicity produced by an impurity of malathion. Toxicol. Appl. Pharmacol. 72: 476-483, 1984.
155. JEFFREY, A. M., WEINSTEIN, I. B., JENNETTE, K. W., GIZESKOWIAK, K., UAKANISHI, K., HARVEY, R. G., AND HARRIS, C.: Studies of benzo[a]pyrene nucleic acid adducts formed in human and bovine bronchial explants. Nature (Lond.) 269: 348-350, 1977.
156. JOHNSON, K. J., FANTONE, J. C., KAPLAN, J., AND WARD, P. A.: In vivo damage of rat lungs by oxygen metabolites. J. Clin. Invest. 67: 983-993, 1981.
157. JONES, B. K., AND HATHAWAY, D. E.: The biological fate of vinylidene chloride in rats. Chem. Biol. Interact. 20: 187-198, 1978.
158. KANEKAL, S., PLOPPER, C., MORIN, D., AND BUCKPITT, A.: Metabolic activation and bronchiolar Clara cell necrosis from naphthalene in the isolated perfused mouse lung. J. Pharmacol. Exp. Ther. 252: 428-437, 1990.
159. KAPANCI, Y., WEIBEL, E. R., KAPLAN, H. P., AND ROBINSON, F. R.: Pathogenesis und reversibility of the pulmonary lesions of oxygen toxicity in monkeys: II - ultrastructural und morphometric studies. Lab. Invest. 20: 101-118, 1969.
160. KAPITULNIK, J., WISLOCKI, A., LEVIN, W., YAGI, H., JERINA, D. M., AND CONNEY, A. H.: Tumorigenicity studies with diol-epoxides of bonzo[a]pyrene which indicate that (±)-trans-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydro-benzo[a]pyrene is an ultimate carcinogen in newborn mice. Cancer Res. 38: 354-358, 1978.
161. KEHRER, J. P.: Free radicals as mediators of tissue injury and diseases. CRC Crit. Rev. Toxicol. 23: 21-48, 1993.
162. KEHRER, J. P., HASCHEK, W. M., AND WITSCHI, H. P.: The influence of hyperoxia on the acute toxicity of paraquat and diquat. Drug Chem. Toxicol. 2: 397-408, 1979.
163. KEHRER, J. P., AND WITSCHI, H. P.: Effects of drug metabolism inhibitors on butylated hydroxytoluene-induced pulmonary toxicity in mice. Toxicol. Appl. Pharmacol. 53: 333-342, 1980.
164. KISTLER, G. S., CALDWELL, P. R. B., AND WEIBEI., E. R.: Development of fine structural damage to alveolar and capillary lining cells in oxygen-poisoned rat lungs. J. Cell. Biol. 33: 605-628, 1967.
165. KLAFF, L. J., LEVIN, P. J., POTGIETER, P. D., LOSMAN, J. G., NOCHOMOVITZ, L. E., AND PERGUSON, A. D.: Treatment of paraquat poisoning with the membrane oxygenator. S. Afr. Med. J. 51: 203-205, 1977.
166. KONNO, N., FUKUTO, T. R., AND IMAMURA, T.: Lung injury and delayed toxicity produced by O,S,S-trimethylphosphorodithioate, an impurity of malathion. Toxicol. Appl. Pharmacol. 75: 219-228, 1984.
167. KRIJGSHELD, K. R., LOWE, M. C., MIMNAGH, E. G., TRUSH, M. A., GINSBURG, E., AND GRAM, T. E.: Lung-selective impairment of cytochrome P450-dependent monooxygenases and cellular injury by 1,1-dichloroethylene in mice. Biochem. Biophys. Res. Commun. 110: 675-681, 1983.
168. KRIJGSHELD, K. R., LOWE, M. C., MIMNAUGH, E. G., TRUSH, M. A., GINSBURG, E., AND GRAM, T. E.: Selective damage to noncilated bronchiolar epithelial cells in relation to impairment of pulmonary monooxygenase activities by 1,1-dichloroethylene in mice. Toxicol. Appl. Pharmacol. 74: 201-213, 1984.
169. KUBOW, S., JANZEN, E. G., AND BRAY, T. M.: Spin-trapping of free radicals formed during in vitro and in vivo metabolism of 3-methylindole. J. Biol. Chem. 289: 4447-4451, 1984.
170. KUHN, C. H.: The cells of the lung. In The Biochemical Basis of Pulmonary Function, ed. by R. G. Crystal, pp. 1-21, Marcel Dekker, Inc., New York, 1976.
171. LABAHADARIOS, D., DAVIS, M., POKTMANN, B., AND WILLIAMS, R.: Paracetamol-induced hepatic necrosis in the mouse: relationship between covalent binding, hepatic glutathione depletion, and the protective effect of α-mercuptopropionylglycine. Biochem. Pharmacol. 31: 3745-3752, 1982.
172. LAEGREID, W. W., AND BREEZE, R. G.: The effect of 3-methylindole on superoxide and hydrogen peroxide production and NADPH oxidation by goat lung microsomes. Res. Commun. Chem. Pathol. Pharmacol. 47: 387-397, 1985.
173. LAZO, J. S., HOLAND, C. J., AND SCHWARTZ, P. E.: Bloomycin hydrolase activity and cytotoxicity in human tumors. Cancer Res. 42: 4026-4031, 1982.
174. LAZO, J. S., HOYT, D. G., SEBTI, S. M., AND PITT, B. R.: The use of
175. LAZO, J. S., AND HUMPHREYS, C. J.: Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity. Proc. Natl. Acad. Sci. USA 80: 3064-3068, 1983.
176. LEE, R. P., AND FORKERT, P. G.: In vitro biotransformation of 1,1-dichloroethylene by hepatic cytochrome P450 2E1 in mice. J. Pharmacol. Exp. Ther. 270: 371-376, 1994.
177. LEE, R. P., AND FORKERT, P. G.: Pulmonary CYP2K1 bioactivates 1,1-dichlorothylene in male and female mice. J. Pharmacol. Exp. Ther. 273: 561-567, 1995.
178. LIEBLER, D. C., AND GUENGERICH, F. P.: Olefin oxidation by cytochrome P450: evidence for group migration in catalytic intermediates formed with vinylidene chloride and trans-1-phenyl-1-butene. Biochemistry 22: 5482-5489, 1983.
179. LIEBLER, D. C., MEREDITH, M. J., AND GUENGERICH, F. P.: Formation of glutathione conjugates by reactive metabolites of vinylidene chloride in microsomes and isolated hepatocytes. Cancer Res. 45: 186-193, 1985.
180. LIN, J. M., DESAI, D. H., MORSE, M. A., AMIN, S., AND HECHT, S. S.: Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone pulmonary metabolism and tumorigenicity in mice by analogues of the investigational chemotherapeutic drug 4-ipomeanol. Chem. Res. Toxicol. 5: 674-679, 1992.
181. LITTERST, C. L., MIMNAUGH, E. G., REAGAN, R. L., AND GRAM, T. E.: Comparison of in vitro drug metabolism by lung, liver and kidney of several common laboratory species. Drug Metab. Dispos. 3: 259-265, 1975.
182. MAHVI, D., BANK, H., AND HARLEY, R.: Morphology of a naphthalene-induced bronchiolar lesion. Am. J. Pathol. 86: 559-572, 1977.
183. MALKINSON, A. M.: Prevention of butylated hydroxytoluene-induced lung damage in mice by cedar terpene administration. Toxicol. Appl. Pharmacol. 49: 551-560, 1979.
184. MALKINSON, A. M., THAETE, L. G., BLUMENTHAL, E. J., AND THOMPSON, J. A.: Evidence for a role of tert-butylhydroxylation in the induction of pneumotoxicity in mice by butylated hydroxytoluene. Toxicol. Appl. Pharmacol. 101: 196-204, 1989.
185. MANSOUR, H., BRUN-PASCAND, M., MARQUETTY, C., POCIDALO, M., HAKIN, J., AND POCIDALO, J.: Protection of rat from oxygen toxicity by inducers of cytochrome P450 system. Am. Rev. Respir. Dis. 137: 608-094, 1988.
186. MARINO, A. A., AND MlTCHELL, J. T.: Lung damage in mice following intraperitoneal injection of butylated hydroxytoluene. Proc. Soc. Exp. Biol. Med. 140: 122-125, 1972.
187. MARTIN, W. J.: Nitrofurantoin: evidence for the oxidant injury of lung parenchymal cells. Am. Rev. Respir. Dis. 127: 482-486, 1983.
188. 2 inhibition of nitro-reductase. Biochem. Biophys. Res. Commun. 67: 1267-1274, 1975.
189. MASUDA, Y., AND NAKAYAMA, N.: Protective action of diethyldithiocarbamate and carbon disulfide against acute toxicities induced by 1,1-dichloroethylene in mice. Toxicol. Appl. Pharmacol. 71: 42-53, 1983.
190. 14C] 3-methylindole metabolite in liver and lung tissues. Comp. Biochem. Physiol. 75C: 395-398, 1983.
191. MILLER, E. C.: Studies on the formation of protein-bound derivatives of 3,4-benzpyrene in the epidermal fraction of mouse skin. Cancer Res. 11: 100-108, 1951.
192. MILLER, J. A.: Research in chemical carcinogenesis with Elizabeth Miller: a trail of discovery with our associates. Drug Metab. Rev. 26: 1-36, 1994.
193. MIZUTANI, T., NOMURA, H., YAMAMOTO, K., AND TAJIMA, K.: Modification of butylated hydroxytoluene-induced pulmonary toxicity in mice by diethyl maleate, buthionine sulfoximine, and cystoine. Toxicol. Lett. 23: 327-331, 1984.
194. MIZUTANI, T., YAMAMOTO, K., AND TAJIMA, K.: Isotope effects on the metabolism and pulmonary toxicity of butylated hydroxytoluene by deuteration of the 4-methyl group. Toxicol. Appl. Pharmacol. 69: 283-290, 1983.
195. MONKS, T. J., HINSON, J. A., AND GILLETTE, J. R.: Bromobenzene and pbromophenol toxicity and covalent binding in vitro. Life Sci. 30: 841-848, 1982.
196. MONKS, T. J., AND LAU, S. S.: Reactive intermediates and their toxicological significance. Toxicology 52: 1-53, 1988.
197. 6-methylguanine formation and metabolism of the tobacco-specific nitrosamine 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Cancer Res. 49: 2894-2897, 1989.
198. MOUSSA, M., AND FORKEKT, P. G.: 1,1-Dichloroethylene-induced alterations in glutathione and covalent binding in murine lung: morphological, histochemical and biochemical studies. J. Pathol. 166: 199-207, 1992.
199. MUGGIA, F. M., LOUIE, A. C., AND SIKIC, B. I.: Pulmonary toxicity of antitumor agents. Cancer Treat. Rev. 10: 221-243, 1983.
200. NAGATA, K., MARTIN, B. M., GILLETE, J. R., AND SASAME, H. A.: Isozymes of cytochrome P450 that metabolize napthalene in liver and lung of untreated mice. Drug Metab. Dispos. 18: 557-564, 1990.
201. NAKAGAWA, Y., HIRAGA, K., AND SUGA, T.: Biological fate of butylated hydroxytuluene (BHT): binding in vitro of BHT to liver microsomes. Chem. Pharm. Bull. (Tokyo) 27: 480-485, 1979a.
202. NAKAGAWA, Y., HIRAGA, K., AND SUGA, T.: Biological fate of butylated hydroxytoluene (BHT): binding in vivo of BHT to macromolecules of rat liver, Chem. Pharm. Bull. (Tokyo) 27: 442-446, 1979b.
203. NAKAGAWA, Y., SUGA, T., AND HIRAGA, K.: Preventive effect of cysteine on butylated hydroxy-toluene-induced pulmonary toxicity in mice. Biochem. Pharmacol. 33: 502-505, 1984.
204. NICHOLS, W. K., LARSON, D. N., AND YOST, G. S.: Bioactivation of 3-methylindole by isolated rabbit lung cells. Toxicol. Appl. Pharmacol. 105: 264-270, 1990.
205. NOCERINI, M. R., CARLSON, J. R., AND YOST, G. S.: Adducts of 3-methylindole and glutathiune: species difference in organ-selective bioactivation. Toxicol. Lett. 28: 79-87, 1985a.
206. NUCERINI, M. R., YOST, G. S., CARLSON, J. R., LIBERATO, D. J., AND BREEZE, R. G.: Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate. Drug Metab. Dispos. 13: 690-694, 1985b.
207. O'BRIEN, K. A., SMITH, L. L., AND COHEN, G. M.: Differences in naphthalene-induced toxicity in the mouse and rat. Chem. Biol. Interact. 55: 109-122, 1985.
208. O'BRIEN, K. A., SUVERKROPP, C., KANEKAI., S., PLOPPER, C. G., AND BUCKPITT, A. R.: Tolerance to multiple doses of the pulmonary toxicant, naphthalene. Toxicol. Appl. Pharmacol. 99: 487-500, 1989.
209. OESCH, F., PROTIC-SABIJIC, M., FRIEDBERG, T., KLIMISCH, H. J., AND GLATT, H. R.: Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis. Carcinogenesis 4: 1031-1038, 1983.
210. OGATA, T., AND MANABE, S.: Correlation between lipid peroxidation and morphological manifestation of paraquat-induced lung injury in rats. Arch. Toxicol. 64: 7-13, 1990.
211. OKEY, A. B., VELLA, L. M., AND HARPER, P. A.: Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice non-responsive to induction of cytochrome P450 by 3-methylcholanthrene. Mol. Pharmacol. 35: 823-830, 1989.
212. OKINE, L. K., GOOCHEE, J. M., AND GRAM, T. E.: Studies on the distribution and covalent binding of 1,1-dichloroethylene in the mouse: effect of various pretreatments on covalent binding in vivo. Biochem. Pharmacol. 34: 4051-4057, 1985.
213. 14C] 1,1-dichloroethylene by mouse liver, kidney, and lung. Biochem. Pharmacol. 35: 2789-2795, 1986.
214. OMAYE, S. T., REDDY, K. A., AND CROSS, C. E.: Enhanced lung toxicity of paraquat in selenium-deficient rats. Toxicol. Appl. Pharmacol. 43: 237-247, 1978.
215. 6-Methylguanine is a critical determinant of 4-(mecnylnitro-samino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res. 51: 5557-5564, 1991.
216. PLOPPER, C. G., CHANG, A. M., PANG, A., AND BUCKPITT, A. H.: Use of micro-dissected airways to define metabolism and cytotoxicity in murine bronchiolar epithelium. Exp. Lung Res. 17: 197-211, 1991a.
217. PLOPPER, C. G., HYDE, D. M., AND BUCKPITT, A. R.: Clara cells. In The Lung: Scientific Foundations, ed. by R. G. Crystal and J. B. West, pp. 215-228, Raven Press, Ltd., New York, 1991b.
218. PLOPPER, C. G., MACKLIN, J., NISHIO, S. J., HYDEN, D. M., AND BUCKPITT, A. R.: Relationship of cytochrome P450 activity to Clara cell cytotoxicity: III - morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters, and rats after parenteral administration of naphthalene. Lab. Invest. 67: 553-565, 1992a.
219. PLOPPER, C. G., SUVERKROPP, C., MORIN, D., NISHIO, S., AND BUCKPITT, A.: Relationship of cytochrome P450 to Clara cell cytotoxicity: I - histopathologic comparison of the respiratory tract of mice, rats, and hamsters after parenteral administration of naphthalene. J. Pharmacol. Exp. Ther. 261: 353-363, 1992b.
220. POPENOE, D.: Effects of paraquat aerosol on mouse lung. Arch. Pathol. Lab. Med. 103: 331-334, 1979.
221. POVIRK, L. F., HOGAN, M., AND GATTAGUPTA, N.: Binding of bleomycin to DNA: intercalation of the bithiazole rings. Biochemistry 18: 96-101, 1979.
222. RASMUSSEN, R. E., Do, D. H., KIM, T. S., AND DEARDEN, L. C.: Comparative cytotoxicity of naphthalene and monomethyl- and mononitro-derivatives in the mouse lung. J. Appl. Toxicol. 6: 13-20, 1986.
223. RAVINDRANATH, V., AND BOYD, M. R.: Metabolic activation of 2-methylfuran by rat microsomal systems. Toxicol. Appl. Pharmacol. 78: 370-376, 1985.
224. RAVINDRANATH, V., BURKA, L. T., AND BOYD, M. R.: Reactive metabolites from the bioactivation of toxic methylfurans. Science (Wash. DC) 224: 884-880, 1984.
225. RAVINDRANATH, V., MCMENAMIN, M. G., DEES, J. H., AND BOYD, M. R.: 2-Methylfuran toxicity in rats: role or metabolic activation in vivo. Toxicol. Appl. Pharmacol. 85: 78-91, 1986.
226. RECKNAGEL, R. O., AND GLENDE, E. A.: Carbon tetrachloride hepatotoxicity: An example or lethal cleavage. Crit. Rev. Toxicol. 2: 263-297, 1973.
227. REID, W., ILETT, K., GLICK, J., AND KRISHNA, G: Metabolism and binding of aromatic hydrocarbons in the lung: relationship to experimental bronchiolar necrosis. Am. Rev. Respir. Dis. 107: 539-551, 1973.
228. REYNOLDS, E. S., KANZ, M. F., CHIECO, P., AND MOSLEN, M. T.: 1,1-Dichloro-ethylene: an apoptotic hepatotoxin. Environ. Health Perspect. 57: 313-320 1984.
229. RHODES, M. L., ZAVALA, D. C., AND BROWN, D.: Hypoxic protection in paraquat poisoning. Lab. Invest. 35: 496-500, 1976.
230. RICHIERI, P. R., AND BUCKPITT, A. R.: Efflux of naphthalene oxide and reactive naphthalene metabolites from isolated hepatocytes. J. Pharmacol. Exp. Ther. 242: 485-491, 1987.
231. RICHIERI, P. R., AND BUCKPITT, A. R.: Glutathione depletion by naphthalene in isolated hepatocytes and by naphthalene oxide in vivo. Biochem. Pharmacol. 37: 2473-2478, 1988.
232. ROSE, M. S., AND SMITH, L. L.: Tissue uptake of paraquat and diquat. Gen. Pharmacol. 8: 173-176, 1977.
233. Ross, J. H., NELSON, G. B., WILSON, K. H., RABINOWITZ, J. R., GALATE, A., STONFR, G. D., NESNOW, S., AND MASS, M. J.: Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels. Cancer Res. 56: 1039-1044, 1995.
234. RUANGYUTTIRARN, W., SKILES, G. L., AND YOST, G. S.: Identification of a cysteinyl adduct of oxidized 3-methylindole from goat lung and human liver microsomal proteins. Chem. Res. Toxicol. 5: 713-719, 1992.
235. RYAN, U. S., AND LI, A. P.: Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue und Cells, pp. 107-122, Pergamon Press, New York, 1993.
236. SCHEULEN, M. E., KAPPUS, H., THYSSEN, D., AND SCHMIDT, C. G.: Redox cycling of Fe (III)-bleomycin by NADPH-cvtochrome P450 reductase. Biochem. Pharmacol. 30: 3385-3388, 1981.
237. SCHRIER, D. J., KUNKEL, R. G., AND PHAN, S. H.: The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am. Rev. Respir. Dis. 127: 63-66, 1983.
238. SEBTI, S. M., AND LAZO, J. S.: Bleomycin hydrolase and tumor resistance to bleomycin. In Anticancer Drugs: Reactive Metabolism and Drug Interactions, ed. by G. Powvis, pp. 387-396, Pergamon Press, New York, 1994.
239. SEBTI, S. M., DELEON, J. C., AND LAZO, J. S.: Purification, characterisation and amino acid composition of rabbit pulmonary bleomycin hydrolase. Biochemistry 26: 4213-4219, 1987.
240. SEBTI, S. M., JANI, J. P., MISTRY, J. S., GORELIK, E., AND LAZO, J. S.: Metabolic inactivation: a mechanism of human tumor resistance to bleomycin. Cancer Res. 51: 227-232, 1991.
241. SEBTI, S. M., AND LAZO, J. S.: Metabolic inactivation of bleomycin analoga by bleomycin hydrolase. Pharmacol. Ther. 38: 321-329, 1988.
242. SEBTI, S. M., MIGNANO, J. E., JANI, J. P., SRITMETKANDADA, S., AND LAZO, J. S.: Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies in the cysteine proteinase family. Biochemistry 28: 6544-6548, 1989.
243. SERABJIT-SINGH, C. J., NISHO, S. J., PHILPOT, R. M., AND PLOPPER, C. G.: The distribution of cytochrome P450 monooxygenase in cells of the rabbit lung: an ultrastructural immunochemical characterization. Mol. Pharmacol. 88 279-289, 1988.
244. SIKIC, B. I., YOUNG, D. M., MIMNAUGH, E. G., AND GRAM, T. E.: Quantification of bleomycin toxicity by changes in lung hydroxyproline content and morphometric histopathology. Cancer Res. 38: 787-792, 1978.
245. SKILLRUD, D. M., AND MARTIN, W. J.: Paraquat-induced injury of type II. alveolar cells: an in vitro model of oxidant injury. Am. Rev. Respir. Dis. 995-999, 1984.
246. SMART, G., AND BUCKPITT, A. R.: Formation of reactive naphthalene metabolites by target vs non-target tissue microsomes: methods for the separation of three glutathione adducts. Biochem. Pharmacol. 32: 943-946, 1983.
247. SMITH, L. J., ANDERSON, J., SHAMSUDDIN, M., AND HSUEH, W.: Effect of fasting on hyperoxic lung damage in mice. Am. Rev. Respir. Dis. 141: 141-144 1990.
248. SMITH, L. L.: Paraquat toxicity. Philos. Trans. R. Soc. London B Biol. Sci. 311 647-657, 1985.
249. SMITH, L. L.: The response of the lung to foreign compounds that produce free radicals. Ann. Rev. Physiol. 48: 681-692, 1986.
250. SMITH, L. L., AND ROSE, M. S.: Biochemical changes in lungs exposed to paraquat. In Biochemical Mechanisms of Paraquat Toxicity, ed. by A. F. Autor, pp. 187-197, Academic Press, Now York, 1977.
251. SMITH, L. L., ROSE, M. S., AND WYATT, I.: The pathology and biochemistry of paraquat. In Oxygen Free Radicals and Tissue Damage (Ciba Foundation Symposium 65), pp. 321-336, Excerpta Medica, Amsterdam, 1979.
252. SMITH, P., AND HEATH, D.: Paraquat. CRC Crit. Rev. Toxicol. 4: 411-445, 1976.
253. SMITH, P., AND HEATH, D.: The ultrastructure and time sequence of the early stages of paraquat lung in rats. J. Pathol. 114: 177-190, 1974.
254. SOMAYAJULU, R. S. N., MUKHERJEE, S. P., LYNN, W. S., AND BENNETT, PPulmonary oxygen toxicity in chickens and rabbits. Undersea Biomed. Rev. 5: 1-8, 1978.
255. Svijarui A. R. A., LEMOLA, M., SLENIUS, B., AND IDANPAAN-HEIKKILA, J.: Nitrofurantoin-induced acute, subacute, and chronic pulmonary reactions. Scand. J. Respir. Dis. 58: 41-50, 1977.
256. Schneider P., AND DEKANT, W.: Renal tumorigenicity of 1,1-dichloroetheno in mice: the role of male-specific expression of cytochrome P450 2E1 in the renal bioactivation of 1,1-dichloroethene. Toxicol. Appl. Pharmacol. 130: 48-56, 1995.
257. STATHAM, C. N., AND BOYD, M. R.: Distribution and metabolism of the pulmonary alkyluting agent and cytotoxin, 4-ipomeanol, in control and diethylmaleate-treated rats. Biochem. Pharmacol. 31: 1585-1589, 1982a.
258. STATHAM, C. N., AND BOYD, M. R.: Effects of phenobarbital and 3-methylcholamathrene on the in vivo distribution, metabolism, and covalent binding of 4-ipomeanol in the rat: implications for target organ toxicity. Biochem. Pharmacol. 31: 3973-3977, 1982b.
259. STEVENS, J. B., AND AUTOR, A. P.: Proposed mechanism for neonatal rat tolerance to normobaric hyperoxia. Fed. Proc. 39: 3138-3143, 1980.
260. THET, L. A., WROBEL., D. J., CRAPO, J. D., AND SHELBURNE, J. D.: Morphologic aspects of the protection of endotoxin against acute and chronic oxygen-induced lung injury in adult rats. Lab. Invest. 48: 448-457, 1983.
261. THORNTON-MANNING, J. R., TUANGYRITTIKARN, W., GONZALEG, J. F., AND YOST, G. S.: Metabolic activation of the pneumotoxin, 3-methylindole, by vaccinia-expressed cytochrome P450s. Biochem. Biophys. Res. Commun. 181: 100-107, 1991.
262. TINDBERG, N., AND INGELMAN-SUNDBERG, M.: Cytochrome P450 and oxygen toxicity: oxygen-dependent induction of ethanol-inducible cytochrome P450 (2E1) in rat liver and lung. Biochemistry 28: 4499-4504, 1989.
263. TONG, S. S., LOWE, M. C., TRUSH, M. A., MIMNAUGH, E. G., GINSBURG, E., HIROKATA, Y., AND GRAM, T. E.: Bronchiolar epithelial damage and impairment of pulmonary microsomal mono-oxygenase activity in mice by naphthalene. Exp. Mol. Pathol. 37: 358-365, 1982.
264. TRUSH, M. A., MIMNAUGH, E. G., GINSBURG, E., AND GRAM, T. E.: In vitro stimulation by paraquat of reactive oxygen-mediated lipid peroxidation in rat lung microsomes. Toxicol. Appl. Pharmacol. 60: 279-286, 1981.
265. TRUSH, M. A., MIMNAUGH, E. G., AND GRAM, T. E.: Commentary: activation of pharmacologic agents to radical intermediates - implications for the role of free radicals in drug action and toxicity. Biochem. Pharmacol. 31: 3335-3346, 1982.
266. TRYKA, A. F., GODLESKI, J. J., AND BRAIN, J. D.; Differences in effects of immediate and delayed hyperoxia exposure on bleomycin-induced pulmonary injury. Cancer Treat. Rep. 68: 759-764, 1984.
267. TURK, M. A., FLORY, W., AND HENK, W. G.: Dose-response in 3-methylindole-induced bronchiolar epithelial necrosis in mice. Res. Commun. Chem. Pathol. Pharmacol. 46: 351-362, 1984.
268. UNITED STATES PUBLIC HEALTH SERVICE: The Health Consequences of Smoking: A Report of the Surgeon General. Department of Health and Human Services, Office on Smoking and Health, Rockville, MD, 1982.
269. VERSCHOYLE, R. D., PHILPOT, R. M., WOLF, C. R., AND DINSDALE, D.: CYP4B1 activates 4-ipomeunol in rat lung. Toxicol. Appl. Pharmacol. 123: 193-198, 1993a.
270. VERSCHOYLE, R. D., WOLF, C. R., AND DINSDALE, D.: Cytochrome P450 2B isoenzymes are responsible for the pulmonary binactivation and toxicity of butylated hydroxytoluene O,O,S-trimethyl-phosphorothioate and methylcyclupentadienyl manganese tricarbonyl. J. Pharmacol. Exp. Ther. 266: 958-963, 1993b.
271. VIJEYARATNAM, G. S., AND CORRIN, B.: Experimental paraquat poisoning: a histological and electron-optical study of the changes in the lung. Pathology 103: 123-129, 1971.
272. VILLASCHI, S., GIOVANETTI, A., LOMBARDI, C. C., NICOLAI, G., GARBATI, M., AND ANDREOZZI, U.: Damage and repair of mouse bronchial epithelium following acute inhalation of trichloroethylene. Exp. Lung Res. 15: 601-614, 1991.
273. WALKER, S. R., HALE, S., MALKINSON, A. M., AND MASON, R. J.: Properties of isolated noncilated bronchiolar cells from mouse lung. Exp. Lung. Res. 15: 553-573, 1989.
274. WAHREN, D. L., BROWN, D. L., AND BUCKPITT, A. R.: Evidence for cytochrome P450 mediated metabolism in the bronchiolar damage by naphthalene. Chem. Biol. Interact. 40: 287-303, 1982.
275. WEBER, C. A., DUNCAN, C. A., LYONS, M. J., AND JENKINSON, S. G.: Depletion of tissue glutathione with diethyl malcate enhances hyperbaric oxygen toxicity. Am. J. Physiol. 258: L308-L312, 1990.
276. WISEMAN, H., AND HALLIWELL, B.: Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313: 17-29, 1996.
277. WITSCHI, H. P., AND COTE, M. G.: Biochemical pathology of lung damage produced by chemicals. Fed. Proc. 35: 89-94, 1976.
278. WITSCHI, H. P., KACEW, S., HIRAI, K. I., AND COTE, M. G.: In vivo oxidation of reduced nicotinamide-adenine dinucleotide phosphate by paraquat and diquat in rat lung. Chem. Biol. Interact. 19: 143-160, 1977.
279. WITSCHI, H. P., MALKINSON, A. M., AND THOMPSON, J. A.: Metabolism and pulmonary toxicity of butaylated hydroxytoluene (BHT). Pharmacol. Ther. 42: 89-113, 1989.
280. WITSCHI, H. P., AND SAHEB, W.: Stimulation of DNA synthesis in mouse lung following intraperitoneal injection of butylated hydroxyltoluene. Proc. Soc. Exp. Riol. Med. 147: 690-693, 1974.
281. WOLF, C. R., STATHAM, C. N., MCMENAMIN, M. G., BEND, ,J. R., BOYD, M. R., AND PHILPOT, R. M.: The relationship between the catalytic activities of rabbit pulmonary cytochrome P450 isozymes and the lung-specific toxicity of the furan-derivative, 4-ipomeanol. Mol. Pharmacol. 22: 738-744, 1982.
282. YOST, G. S.: Mechanisms of 3-methylindole pneumototoxicity. Chem. Res. Toxicol. 2: 273-279, 1989.